Please check the individual session for location or broadcast availability.
Terzah Horton, MD, PhD
Johnathan Flanagan, PhD
Target Audience and Needs
Clinical and research faculty, graduate and medical students, clinical and postdoctoral fellows, and clinical and research nurses in pediatric hematology-oncology need to receive regular updates on the latest clinical trial data concerning hematological-oncological disorders in children and advances in targeted therapies for these disorders. Learners also need regular reviews of the ethical and legal issues surrounding end-of-life care and of the evolving practice standards for follow-up care for long-term survivors of hematological-oncological disorders. The series aims to increase the knowledge and skills of the learners to enhance the quality of healthcare, increase patient safety, and improve patient outcomes.
Educational methods will include lectures, case presentations, literature review, and panel discussion.
At the conclusion of the sessions, the participants should be able to:
- Discuss new research data in pediatric hematologic and oncologic disorders and incorporate these data into clinical and research activities.
- Identify ethical and legal issues pertaining to clinical care and research activities pertaining to pediatric hematology and oncology.
- Evaluate drug development for pediatric malignancies and blood disorders.
- Analyze and interpret the significance of long-term survivorship issues related to pediatric malignancies and hematologic disorders.
- Recognize how quality improvement cycles can be applied to a specific and common clinical problem.
- Develop strategies to improve communication between clinical teams in different medical settings.
Participants may be asked to complete a session evaluation.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.